Pacific Biosciences Of California (PACB) Other Non-Current Liabilities (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Other Non-Current Liabilities of $8.0 million for Q1 2026, down 57.22% quarter-over-quarter from $18.7 million in Q4 2024.
Pacific Biosciences Of California (PACB) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Other Non-Current Liabilities history runs 15 years deep, the most recent figure standing at $8.0 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $8.0 million (changed N/A YoY), while the FY2024 annual figure was $18.7 million, up 2390.01% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $8.0 million, down from $18.7 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $184.4 million in Q1 2023, with the low at $751000.0 in Q4 2023.
- The 4-year median for Other Non-Current Liabilities is $18.4 million (2023), against an average of $46.7 million.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities jumped 21604.26% in 2022, then plunged 99.59% in 2024.
- Pacific Biosciences Of California's Other Non-Current Liabilities stood at $1.3 million in 2022, then slumped by 42.23% to $751000.0 in 2023, then surged by 2390.01% to $18.7 million in 2024, then tumbled by 57.22% to $8.0 million in 2026.
- Business Quant data shows PACB's Other Non-Current Liabilities at $8.0 million in Q1 2026, $18.7 million in Q4 2024, and $20.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 394.84 Mn | 157.97 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.20 Mn |
| Mar 31, 2026 | 8.00 Mn |
| Dec 31, 2024 | 18.70 Mn |
| Sep 30, 2024 | 20.65 Mn |
| Jun 30, 2024 | 19.48 Mn |
| Mar 31, 2024 | 751,000.00 |
| Dec 31, 2023 | 751,000.00 |
| Sep 30, 2023 | 18.45 Mn |
| Jun 30, 2023 | 837,000.00 |
| Mar 31, 2023 | 184.35 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 167.50 Mn |
| Jun 30, 2022 | 163.22 Mn |
| Mar 31, 2022 | 3.22 Mn |
| Dec 31, 2021 | 169.72 Mn |
| Sep 20, 2021 | 200.00 Mn |
| Jun 30, 2021 | 752,000.00 |
| Mar 31, 2021 | 752,000.00 |
| Dec 31, 2020 | 752,000.00 |
| Dec 31, 2018 | 16,000.00 |